FLUIDIGM (DELAWARE) Stock Price, News & Analysis
Company Description
FLUIDIGM (DELAWARE) (NASDAQ: fldm) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $286.4M.
fldm stock has declined 21.2% over the past year.
This page provides a comprehensive overview of fldm stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
FLUIDIGM (DELAWARE) (fldm) stock. Over the past 12 months, the stock has lost 21.2%. At a market capitalization of $286.4M, fldm is classified as a micro-cap stock with approximately 77.2M shares outstanding.
Latest News
FLUIDIGM (DELAWARE) has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings. View all fldm news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
fldm Company Profile & Sector Positioning
FLUIDIGM (DELAWARE) (fldm) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing fldm often look at related companies in the same sector, including Exagen Inc. (XGN), Mdxhealth Sa (MDXH), Prenetics Ltd (PRE), Fonar Corp (FONR), and Burning Rock Biotech Ltd (BNR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate fldm's relative position within its industry.